MyFinsight
Home
Blog
About
Change in fair value of
warrant liability
-$9,443K
(-174.12%↓ Y/Y)
Foreign currency
transaction gain, net
$664K
(-60.43%↓ Y/Y)
Interest income, net
$378K
(-16.74%↓ Y/Y)
Upfront License Fees
$600K
(-76.30%↓ Y/Y)
Event Based
Milestones And Other...
$343K
Total other income
(expenses)
$10,467K
(198.89%↑ Y/Y)
Other income
(expense), net
-$18K
(-169.23%↓ Y/Y)
Total revenues under
collaborative agreements
$943K
(-62.76%↓ Y/Y)
Royalties, license and
other revenues
$126K
(-45.92%↓ Y/Y)
Net loss
$1,544K
(105.08%↑ Y/Y)
Loss from operations
-$8,923K
(54.89%↑ Y/Y)
Total revenues
$1,069K
(-61.34%↓ Y/Y)
Net income (gain)
$1,544K
(105.08%↑ Y/Y)
Total operating
expenses
$9,992K
(-55.68%↓ Y/Y)
Net income (gain)
attributable to lineage
$1,482K
(104.86%↑ Y/Y)
Net (income) loss
attributable to...
$62K
(-38.00%↓ Y/Y)
General and
administrative
$5,218K
(14.43%↑ Y/Y)
Research and development
$4,774K
(53.70%↑ Y/Y)
Back
Back
Income Statement
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX)
source: myfinsight.com